ATS3B antibody is an antibody that binds to the B-type terminal trisaccharide (BTS) . Antibodies are glycoproteins, with the fragment antigen-binding region (Fab region) containing sites that bind to antigens. The paratope, shaped by variable domains from heavy and light chains, defines the antigen-binding specificity .
ATS3B antibodies, naturally occurring in serum, are significant in medicine due to their specificity for A and B blood group isoantigens . An enzyme-linked immunosorbent assay (ELISA) is able to detect all ATS/BTS-binding antibodies. This assay, combined with limiting-dilution methodology, allows monoclonal analysis of the human antibody repertoire specific for ATS and BTS in individuals with different blood types .
Studies of tumor-infiltrating B cells (TIL-Bs) reveal characteristics like high clonal polarization and elevated somatic hypermutation rates . TIL-Bs exhibit lower clonal diversity, suggesting B cell clonal proliferation within tumor tissue. The B cell response in the draining lymph nodes (DLNs) also shows high clonal polarization .
The complementarity-determining region 3 (CDRH3) length in TIL-B clones is longer than that of B cell clones in the bone marrow of naive mice, indicating that TIL-Bs may undergo positive selection as part of the affinity maturation stage .
Bispecific antibodies (bsAbs) are under investigation to improve efficacy, safety, and production in cancer therapy. A trispecific antibody (CD38/CD3 × CD28) has demonstrated the ability to inhibit apoptosis of CD4+ or CD8+ T cells, stimulate human CD4 and CD8 T cell proliferation, and display superior cytolytic activity against human myeloma cell lines compared to daratumumab. This trispecific antibody also enhances T cell killing against CD28-expressing multiple myeloma cells and provides significant protection against disseminated human MM cell tumor growth in a humanized mouse model .
| Feature | Description |
|---|---|
| Antibody Type | Binds to B-type terminal trisaccharide (BTS) |
| Significance | Important in medicine due to specificity for A and B blood group isoantigens |
| Research Area | Tumor-infiltrating B cells (TIL-Bs), bispecific and trispecific antibody engineering |
| Clonal Diversity | TIL-Bs exhibit lower clonal diversity, suggesting B cell clonal proliferation within tumor tissue |
| CDRH3 Length | CDRH3 length in TIL-B clones is longer than that of B cell clones in the bone marrow of naive mice, indicating positive selection |
| Trispecific Antibody (CD38/CD3 × CD28) | Inhibits apoptosis of CD4+ or CD8+ T cells, stimulates human CD4 and CD8 T cell proliferation, and displays superior cytolytic activity against human myeloma cell lines compared to daratumumab |
ATS3B (Embryo-specific protein 3B) is a protein encoded by the AT5G62200 gene in Arabidopsis thaliana. This protein was initially identified through differential display of mRNA as an embryo-specific gene . The significance of ATS3B stems from its roles in:
Embryonic development in Arabidopsis
Stress response mechanisms
Stomatal regulation (particularly closure)
Potential roles in plant defense against pathogens
Research has demonstrated that ATS3B interacts with other proteins such as ArathEULS3 (a lectin involved in drought stress response) in closed stomata, suggesting a role in stress-related signaling pathways . Understanding ATS3B function provides insights into fundamental plant developmental and stress adaptation mechanisms.
Based on available research antibodies and protocols, ATS3B antibodies can be utilized in several detection methods:
Western Blotting (WB): For detecting the ATS3B protein in tissue lysates and determining protein size/expression levels
Immunohistochemistry (IHC): For localizing ATS3B in tissue sections
Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative measurement of ATS3B
Immunocytochemistry (ICC): For subcellular localization studies
The selection of method depends on your specific research question. For instance, when investigating protein-protein interactions involving ATS3B, bimolecular fluorescence complementation experiments have been successfully employed to confirm interactions between ArathEULS3 and ATS3B in closed stomata of Nicotiana benthamiana plants .
Proper antibody selection and validation are critical for reliable results. Follow these methodological steps:
Antibody Type Selection: Consider polyclonal antibodies for higher sensitivity (like those raised in rabbits against ATS3B ). Monoclonal antibodies provide higher specificity but may be less available for ATS3B.
Species Reactivity: Verify that the antibody specifically recognizes ATS3B from your species of interest. Most available antibodies are designed for Arabidopsis thaliana .
Application Validation: Confirm the antibody has been validated for your intended application (WB, IHC, ICC). Look for published studies and validation data from manufacturers.
Epitope Information: Review the immunogen information. For ATS3B antibodies, some are generated against recombinant Arabidopsis thaliana ATS3B protein .
Controls for Validation:
Positive control: Use tissues known to express ATS3B (such as Arabidopsis embryonic tissues)
Negative control: Use tissues where ATS3B is not expressed or ATS3B knockout lines
Blocking peptide: To confirm specificity of signal
Cross-reactivity testing: Especially important when working with related proteins
Documentation: Always record antibody catalog numbers, lot numbers, and dilutions used for reproducibility.
When designing co-immunoprecipitation (Co-IP) experiments to study ATS3B interactions:
Sample Preparation:
Fresh plant tissue is preferable (embryonic tissue or tissues where ATS3B is known to be expressed)
Use a gentle lysis buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, protease inhibitors)
Maintain cold conditions throughout to preserve protein complexes
Antibody Binding:
Pre-clear lysate with protein A/G beads to reduce nonspecific binding
Incubate cleared lysate with ATS3B antibody (typically 2-5 μg of antibody per 500 μg of protein)
Allow binding to occur overnight at 4°C with gentle rotation
Controls:
Include a negative control with IgG from the same species as the ATS3B antibody
Include a sample from ATS3B knockout or knockdown plants
Consider a reciprocal Co-IP when possible (using antibodies against suspected interaction partners)
Verification of Interactions:
Analysis of Results:
Analyze by Western blotting, probing for both ATS3B and the interacting protein
Consider protein complex stability when interpreting negative results
Based on published research showing ATS3B's involvement in stomatal closure , the following methodological approach is recommended:
Tissue Selection:
Use leaf epidermal peels or intact leaves from plants at appropriate developmental stages
Consider comparing wild-type, ATS3B overexpression, and ATS3B knockdown/knockout lines
Immunolocalization Protocol:
Fix tissue samples with 4% paraformaldehyde
Permeabilize with 0.1% Triton X-100
Block with 3% BSA
Incubate with ATS3B primary antibody (optimal dilution typically 1:100 to 1:500)
Use appropriate fluorophore-conjugated secondary antibody
Include DAPI staining for nuclei visualization
Stimulus Testing:
Apply relevant stimuli (ABA, drought, pathogen-associated molecular patterns)
Perform time-course experiments to capture dynamic changes
Quantification Methods:
Measure stomatal aperture changes
Quantify ATS3B protein levels and localization before and after stimulus
Correlate with functional stomatal responses
Combined Approaches:
Use bimolecular fluorescence complementation to visualize protein interactions in guard cells
Consider co-staining with markers for relevant cellular compartments
| Issue | Potential Causes | Solutions |
|---|---|---|
| High background signal | Non-specific binding, excessive antibody concentration, inadequate blocking | Increase blocking time/concentration, titrate antibody, add 0.1-0.3% Tween-20 to wash buffer, pre-absorb antibody |
| No signal detection | Low ATS3B expression, epitope masking, antibody deterioration | Use tissues with known high expression, try different epitope retrieval methods, verify antibody activity with positive control |
| Multiple bands in Western blot | Post-translational modifications, degradation products, cross-reactivity | Include protease inhibitors during extraction, optimize sample preparation, perform peptide competition assay |
| Inconsistent results | Variations in experimental conditions, antibody lot variations | Standardize protocols, record lot numbers, include internal controls in each experiment |
| Poor signal in fixed tissues | Over-fixation, epitope masking | Optimize fixation time, try different antigen retrieval methods, consider using fresh-frozen sections |
To methodically confirm antibody specificity:
Genetic Approaches:
Biochemical Approaches:
Perform peptide competition assays using the immunogenic peptide
Conduct immunoprecipitation followed by mass spectrometry to confirm the identity of the pulled-down protein
Multiple Antibody Validation:
Use antibodies raised against different epitopes of ATS3B
Compare results from monoclonal and polyclonal antibodies when available
Cross-species Validation:
Test the antibody in closely related species where the epitope is conserved
Compare expression patterns with known tissue-specific expression data
Correlation with mRNA Expression:
Compare protein detection patterns with mRNA expression (RT-PCR or RNA-seq data)
Verify temporal and spatial expression patterns match known patterns for ATS3B
To investigate ATS3B's role in stress signaling:
Stress Treatment Experimental Design:
Expose plants to relevant stresses (drought, pathogens, ABA)
Collect samples at multiple time points (0, 1, 3, 6, 12, 24 hours)
Process parallel samples for protein extraction and microscopy
Protein Complex Dynamics Analysis:
Conduct co-immunoprecipitation with ATS3B antibodies before and after stress
Analyze interacting partners by mass spectrometry
Compare interaction profiles under different stress conditions
Phosphorylation Status Analysis:
Perform immunoprecipitation with ATS3B antibodies
Analyze phosphorylation status using phospho-specific antibodies or mass spectrometry
Correlate changes with stress response timing
Subcellular Localization Changes:
Use immunofluorescence microscopy to track ATS3B localization during stress
Co-stain with organelle markers to determine translocation events
Quantify changes in localization patterns
Correlation with Physiological Responses:
Measure stomatal aperture, transpiration rates, or pathogen resistance
Correlate with ATS3B protein levels, modifications, and interactions
Compare wild-type responses with those in ATS3B-modified plants
Research has shown that during bacterial infection of Arabidopsis thaliana plants, there was a 6-fold increase in transcript levels for ArathEULS3, which interacts with ATS3B . This suggests ATS3B may play a role in pathogen response pathways.
Based on published research on ATS3B-ArathEULS3 interaction , the following methodological approaches are recommended:
In vivo Interaction Visualization:
Bimolecular fluorescence complementation (BiFC): Split YFP or similar fluorescent protein between ATS3B and ArathEULS3, observe reconstituted fluorescence in guard cells
FRET analysis: Tag proteins with compatible fluorophores to measure energy transfer indicating close proximity
Split-luciferase complementation assays in transiently transformed leaves
Dynamic Interaction Analysis:
Apply ABA or pathogen-associated molecular patterns and observe changes in interaction
Perform time-course studies following stimulus application
Correlate interaction intensity with stomatal aperture changes
Domain Mapping:
Generate truncated versions of both proteins to identify interaction domains
Perform site-directed mutagenesis of key residues
Verify effects on interaction and stomatal function
Functional Analysis:
Compare stomatal responses in wild-type, single mutants (ATS3B or ArathEULS3), and double mutants
Perform complementation studies with mutated versions of either protein
Correlate interaction strength with functional outputs
Protein Modification Effects:
Investigate post-translational modifications affecting the interaction
Test conditions that might regulate the interaction (pH, calcium levels, redox state)
Studies have confirmed interactions between ArathEULS3 and ATS3B in closed stomata of Nicotiana benthamiana plants using BiFC experiments . Plants with reduced ArathEULS3 expression exhibited aberrant ABA-induced stomatal closure compared to overexpressing and control plants, suggesting a functional relationship between these interacting proteins.
When analyzing variations in ATS3B signal across tissues and developmental stages:
Expression Pattern Analysis:
Developmental Timeline Considerations:
Document precise developmental stages using standardized growth stage definitions
Consider normal developmental regulation when interpreting apparent changes
Create developmental expression maps to identify critical transition points
Standardization Approaches:
Always normalize to appropriate loading controls (housekeeping proteins)
Consider using recombinant ATS3B standards for absolute quantification
Include reference tissues in each experiment for relative comparisons
Tissue-Specific Variables:
Account for tissue-specific extraction efficiency differences
Consider cell-type heterogeneity within tissue samples
Use cell-type specific markers when performing immunolocalization
Biological vs. Technical Variation:
Distinguish between biological replicates (different plants) and technical replicates
Use statistical methods appropriate for the experimental design
Report both types of variation when presenting results
Research has shown that ATS3B exhibits spatial expression patterns similar to Arabidopsis seed storage protein genes , which should be considered when interpreting expression data.
To evaluate the biological significance of ATS3B post-translational modifications (PTMs):
Conservation Analysis:
Examine if the modified residues are conserved across species
Compare with related proteins (such as ATS3A) to identify conserved modification sites
Higher conservation suggests functional importance
Correlation with Biological Events:
Track modification status during development and stress responses
Correlate changes with phenotypic outputs (stomatal closure, stress resistance)
Establish temporal relationships between modification and downstream events
Functional Impact Assessment:
Generate site-directed mutants that mimic or prevent modification
Test mutants for altered function in relevant assays
Assess impacts on protein-protein interactions, particularly with known partners like ArathEULS3
Enzymatic Regulation:
Identify enzymes responsible for the modifications
Use inhibitors or genetic approaches to modulate these enzymes
Observe resulting changes in ATS3B function
Structural Considerations:
Model the impact of modifications on protein structure
Predict effects on interaction surfaces or functional domains
Test predictions through experimental approaches
While specific information on ATS3B post-translational modifications is limited in the provided search results, research in plant biology often reveals that PTMs play crucial roles in regulating protein function, especially in stress responses and developmental transitions.